CL2009001349A1 - Compuestos derivados de urea sustituidos con 1,4-dihidroquinolin-4-ona, inhibidores de adn girasa bacteriana y/o topoisomerasa iv bacteriana; composicion farmceutica; util para el tratamiento de una infeccion bacteriana. - Google Patents
Compuestos derivados de urea sustituidos con 1,4-dihidroquinolin-4-ona, inhibidores de adn girasa bacteriana y/o topoisomerasa iv bacteriana; composicion farmceutica; util para el tratamiento de una infeccion bacteriana.Info
- Publication number
- CL2009001349A1 CL2009001349A1 CL2009001349A CL2009001349A CL2009001349A1 CL 2009001349 A1 CL2009001349 A1 CL 2009001349A1 CL 2009001349 A CL2009001349 A CL 2009001349A CL 2009001349 A CL2009001349 A CL 2009001349A CL 2009001349 A1 CL2009001349 A1 CL 2009001349A1
- Authority
- CL
- Chile
- Prior art keywords
- bacterial
- useful
- pharmaceutical composition
- dihydroquinolin
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Compuestos derivados de urea heterocíclicos, composición farmacéutica, útil para preparar un medicamento inhibidor de la ADN girasa bacteriana y/o topoisomerasa IV bacteriana y por lo tanto útil para tratar una infección bacteriana.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5873608P | 2008-06-04 | 2008-06-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2009001349A1 true CL2009001349A1 (es) | 2010-12-31 |
Family
ID=40823415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2009001349A CL2009001349A1 (es) | 2008-06-04 | 2009-06-03 | Compuestos derivados de urea sustituidos con 1,4-dihidroquinolin-4-ona, inhibidores de adn girasa bacteriana y/o topoisomerasa iv bacteriana; composicion farmceutica; util para el tratamiento de una infeccion bacteriana. |
Country Status (23)
Country | Link |
---|---|
US (1) | US8283361B2 (es) |
EP (1) | EP2300463A1 (es) |
JP (1) | JP2011522026A (es) |
KR (1) | KR20110014710A (es) |
CN (1) | CN102105469A (es) |
AR (1) | AR072045A1 (es) |
AU (1) | AU2009254930A1 (es) |
BR (1) | BRPI0915471A2 (es) |
CA (1) | CA2725568A1 (es) |
CL (1) | CL2009001349A1 (es) |
CO (1) | CO6382176A2 (es) |
CR (1) | CR11825A (es) |
DO (1) | DOP2010000373A (es) |
EA (1) | EA201001858A1 (es) |
EC (1) | ECSP10010664A (es) |
IL (1) | IL209503A0 (es) |
MX (1) | MX2010013310A (es) |
PE (1) | PE20100155A1 (es) |
SV (1) | SV2010003752A (es) |
TW (1) | TW201000475A (es) |
UY (1) | UY31864A (es) |
WO (1) | WO2009147433A1 (es) |
ZA (1) | ZA201008610B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1849465A4 (en) * | 2005-02-18 | 2008-12-24 | Takeda Pharmaceutical | AGENT FOR CONTROLLING THE FUNCTION OF THE GPR34 RECEPTOR |
TW201102065A (en) * | 2009-05-29 | 2011-01-16 | Astrazeneca Ab | Heterocyclic urea derivatives and methods of use thereof |
UY32694A (es) * | 2009-06-08 | 2011-01-31 | Astrazeneca Ab | Derivados heterocíclicos de urea y métodos de uso de los mismos |
JP2013523715A (ja) | 2010-03-31 | 2013-06-17 | アクテリオン ファーマシューティカルズ リミテッド | イソキノリン−3−イル尿素誘導体 |
AR088729A1 (es) | 2011-03-29 | 2014-07-02 | Actelion Pharmaceuticals Ltd | Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica |
CN105067814A (zh) * | 2015-07-24 | 2015-11-18 | 中国科学院成都生物研究所 | 解旋酶水解atp活性测定方法 |
WO2018048882A1 (en) | 2016-09-06 | 2018-03-15 | The Research Foundation For The State University Of New York | Positron imaging tomography imaging agent composition and method for bacterial infection |
WO2018074880A2 (ko) * | 2016-10-20 | 2018-04-26 | 한국화학연구원 | 퀴놀린 4-온 유도체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 폐렴의 예방 또는 치료용 약학적 조성물 |
EP3604281A4 (en) | 2017-03-24 | 2020-08-19 | Taisho Pharmaceutical Co., Ltd. | 2 (1H) -CHINOLINONE DERIVATIVE |
CN111808089B (zh) * | 2019-04-10 | 2023-04-11 | 四川大学华西医院 | 一种治疗糖尿病的药物依格列净或其衍生物的制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0589985A1 (en) | 1991-06-21 | 1994-04-06 | Boehringer Mannheim Italia S.P.A. | 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract |
ES2331250T3 (es) | 2000-12-15 | 2009-12-28 | Vertex Pharmaceuticals Incorporated | Inhibidores de la girasa bacteriana y usos de los mismos. |
AR042956A1 (es) | 2003-01-31 | 2005-07-13 | Vertex Pharma | Inhibidores de girasa y usos de los mismos |
CN101171247A (zh) * | 2005-03-04 | 2008-04-30 | 阿斯利康(瑞典)有限公司 | 作为dna促旋酶和拓扑异构酶抑制剂的吡咯衍生物 |
US8022816B2 (en) | 2005-03-21 | 2011-09-20 | Vela Systems, Inc. | System and method for field management using radio frequency tags |
US7569907B2 (en) | 2005-03-28 | 2009-08-04 | Cooper Technologies Company | Hybrid chip fuse assembly having wire leads and fabrication method therefor |
KR20070119032A (ko) | 2005-04-13 | 2007-12-18 | 코닌클리케 필립스 일렉트로닉스 엔.브이. | 위상 변조 이전에 워터마킹을 통한 인코딩 |
US20080312211A1 (en) * | 2005-12-23 | 2008-12-18 | Astrazeneca Ab | Antibacterial Pyrrolopyridines, Pyrrolopyrimidines and Pyrroloazepines-154 |
DE102006012337B3 (de) | 2006-03-17 | 2007-11-29 | Amphenol-Tuchel Electronics Gmbh | Elektrischer Steckverbinder |
EP2102199B1 (en) * | 2006-12-04 | 2011-04-27 | AstraZeneca AB | Antibacterial polycyclic urea compounds |
CN201038186Y (zh) | 2007-03-08 | 2008-03-19 | 鹤山丽得电子实业有限公司 | 一种大功率led |
TW200940537A (en) | 2008-02-26 | 2009-10-01 | Astrazeneca Ab | Heterocyclic urea derivatives and methods of use thereof |
WO2009110688A2 (ko) | 2008-03-06 | 2009-09-11 | Jang Gum Sik | 태양광 발전 장치 |
UY32694A (es) * | 2009-06-08 | 2011-01-31 | Astrazeneca Ab | Derivados heterocíclicos de urea y métodos de uso de los mismos |
-
2009
- 2009-06-03 CA CA2725568A patent/CA2725568A1/en not_active Abandoned
- 2009-06-03 UY UY0001031864A patent/UY31864A/es not_active Application Discontinuation
- 2009-06-03 US US12/477,781 patent/US8283361B2/en not_active Expired - Fee Related
- 2009-06-03 WO PCT/GB2009/050611 patent/WO2009147433A1/en active Application Filing
- 2009-06-03 AU AU2009254930A patent/AU2009254930A1/en not_active Abandoned
- 2009-06-03 EA EA201001858A patent/EA201001858A1/ru unknown
- 2009-06-03 TW TW098118462A patent/TW201000475A/zh unknown
- 2009-06-03 KR KR1020117000030A patent/KR20110014710A/ko not_active Application Discontinuation
- 2009-06-03 CN CN2009801294194A patent/CN102105469A/zh active Pending
- 2009-06-03 JP JP2011512216A patent/JP2011522026A/ja active Pending
- 2009-06-03 MX MX2010013310A patent/MX2010013310A/es not_active Application Discontinuation
- 2009-06-03 EP EP09757805A patent/EP2300463A1/en not_active Withdrawn
- 2009-06-03 BR BRPI0915471A patent/BRPI0915471A2/pt not_active IP Right Cessation
- 2009-06-03 CL CL2009001349A patent/CL2009001349A1/es unknown
- 2009-06-04 AR ARP090102012A patent/AR072045A1/es unknown
- 2009-06-04 PE PE2009000774A patent/PE20100155A1/es not_active Application Discontinuation
-
2010
- 2010-11-22 IL IL209503A patent/IL209503A0/en unknown
- 2010-11-30 ZA ZA2010/08610A patent/ZA201008610B/en unknown
- 2010-12-03 DO DO2010000373A patent/DOP2010000373A/es unknown
- 2010-12-06 CR CR11825A patent/CR11825A/es not_active Application Discontinuation
- 2010-12-06 SV SV2010003752A patent/SV2010003752A/es not_active Application Discontinuation
- 2010-12-07 EC EC2010010664A patent/ECSP10010664A/es unknown
- 2010-12-22 CO CO10160874A patent/CO6382176A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20100155A1 (es) | 2010-03-25 |
AR072045A1 (es) | 2010-08-04 |
EA201001858A1 (ru) | 2011-08-30 |
JP2011522026A (ja) | 2011-07-28 |
ECSP10010664A (es) | 2011-01-31 |
IL209503A0 (en) | 2011-01-31 |
WO2009147433A1 (en) | 2009-12-10 |
MX2010013310A (es) | 2011-03-01 |
CO6382176A2 (es) | 2012-02-15 |
KR20110014710A (ko) | 2011-02-11 |
CR11825A (es) | 2011-02-04 |
US20100190745A1 (en) | 2010-07-29 |
EP2300463A1 (en) | 2011-03-30 |
AU2009254930A1 (en) | 2009-12-10 |
BRPI0915471A2 (pt) | 2017-06-27 |
SV2010003752A (es) | 2011-04-14 |
CN102105469A (zh) | 2011-06-22 |
US8283361B2 (en) | 2012-10-09 |
ZA201008610B (en) | 2012-08-29 |
UY31864A (es) | 2010-01-29 |
DOP2010000373A (es) | 2011-01-15 |
CA2725568A1 (en) | 2009-12-10 |
TW201000475A (en) | 2010-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2009001349A1 (es) | Compuestos derivados de urea sustituidos con 1,4-dihidroquinolin-4-ona, inhibidores de adn girasa bacteriana y/o topoisomerasa iv bacteriana; composicion farmceutica; util para el tratamiento de una infeccion bacteriana. | |
CL2011000838A1 (es) | Compuestos heterociclicos derivados de tetraciclos ortocondensados con un grupo pirimidina 2,4,6-triona espirocondensado, inhibidores de la adn girasa bacteriana; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una infeccion bacteriana. | |
CL2009001346A1 (es) | Compuestos derivados heterociclicos, inhibidores de la adn girasa; proceso de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion bacteriana. | |
GEP20146060B (en) | Pyridyl inhibitors of hedgehog signalling | |
CL2009000426A1 (es) | Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas | |
CL2007003495A1 (es) | Compuestos derivados de heterociclos condensados sustituidos, inhibidores de la actividad de la akt; composicion farmaceutica; y uso para el tratamiento o prevencion del cancer. | |
CL2007003758A1 (es) | Compuestos derivados de aminopirimidina, inhibidores de plk1; composicion farmaceutica, util para el tratamiento de cancer. | |
CL2008001740A1 (es) | Compuestos derivados de piperidinas sustituidas, inhibidores de la dna-girasa y/o topoisomerasa iv; procedimeinto para su preparacion; composiicon farmaceutica que comprende estos compustos y su uso en el tratamiento de una infeccion bacteriana. | |
EA200900798A1 (ru) | Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы | |
UA110199C2 (en) | Solid rifaximin dispersion | |
CL2007002100A1 (es) | Compuestos derivados biciclicos que contienen nitrogeno, sus sales, solvatos y n-oxidos; composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas. | |
TW200736229A (en) | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors | |
BRPI0815057A2 (pt) | Composto, composição farmacêutica, e, método para tratar infecção. | |
CO6511251A2 (es) | Compuestos quimicos | |
CL2011001333A1 (es) | Compuestos derivados de heterociclos nitrogenados sustituidos, inhibidores de ns5a; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c. | |
MX2009006481A (es) | Derivados de imidazol 1-sustituidos, y su uso como inhibidores de la sintasa de aldosterona. | |
EA201170772A1 (ru) | Органические соединения | |
EA200970738A1 (ru) | Ингибиторы активности akt | |
WO2010038081A3 (en) | 4-amino-5- (hetero) aryl-2-phenylamino-pyrimidine or pyridine and their use as dna gyrase and/or topoisomerase iv inhibitors | |
BRPI0815606A2 (pt) | Derivados de 6-triazol piridazina - sulfanil benzotiazol e benzimidazol, o respectivo processo de preparo, a respectiva aplicação a título de medicamentos, composições farmacêuticas e utilização, notadamente como inibidores de met. | |
MX2009006630A (es) | Derivados de 4-imidazolil-1,2,3,4-tetrahidro-quinola y su uso como inhibidores de aldosterona / 11-beta-hidroxilasa. | |
CL2011000957A1 (es) | Compuesto derivados de isoindolina sustituidos, inhibidores de citosinas tnf-a; composicion farmaceutica; utiles en el tratamiento del cancer. | |
MX2009014247A (es) | Compuestos heterociclicos utiles como inhibidores de mk2. | |
EA201200174A1 (ru) | Производные оксазина и их применение в качестве ингибиторов bace для лечения неврологических нарушений | |
ECSP088676A (es) | Pirazolquinolonas como potentes inhibidores de parp |